No recent analyst price targets found for SCS.
Latest News for SCS
Saluda Medical Expands Access to First and Only FDA-Approved Closed-Loop Surgical Paddle Lead with Full US Commercial Release of CAP24™
Saluda Medical Expands Access to First and Only FDA-Approved Closed-Loop Surgical Paddle Lead with Full US Commercial Release of CAP24â¢PR NewswireBLOOMINGTON,
HNI Corporation: Workplace Recovery And Steelcase Synergies Support A Buy
HNI is rated Buy, driven by cyclical Workplace recovery, Steelcase integration, and attractive valuation. Workplace order growth, backlog strength, and macro tailwinds signal accelerating revenue and multi-year earnings growth potential. Steelcase acquisition offers significant cost synergy upside, with cross-selling and margin expansion opportunities not fully reflected in forecasts.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SCS.
U.S. House Trading
No House trades found for SCS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.